Prospective randomized double-blind placebo controlled trial of recombinant human erythropoietin administration to reduce blood transfusions in anemic pediatric intensive care patients.
The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG Apr, 2006 | Pubmed ID: 23118648